# An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

> **NCT00185068** · PHASE4 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 110 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Olmesartan medoxomil
- **DRUG:** Olmesartan medoxomil/hydrochlorothiazide
- **DRUG:** Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00185068
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 110 (—)
- **Last updated:** 2005-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00185068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00185068, "An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00185068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*